New agonists of the incretin/glucagon system for the treatment of metabolic dysfunction-associated steatohepatitis. Mullish BH. Gastroenterology 2024 Nov 30:S0016-5085(24)05755.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mullish BH. New agonists of the incretin/glucagon system for the treatment of metabolic dysfunction-associated steatohepatitis. Gastroenterology 2024 Nov 30:S0016-5085(24)05755.
PMID: 39622299